and downturned corners of the mouth. Some PWS individuals also have hypopigmented hair and skin with features of ocular albinism.
PWS affects ∼ 1/15,000 to 1/30,000 individuals worldwide and equally occurs across both genders and all races [Butler JV et al., 2002; Butler MG et al., 2006; Angulo et al., 2015; Kweh et al., 2015; Driscoll et al., 2016] . Most cases are suspected to have PWS in infancy by their weak cry, poor suck and feeding problems, as well as hypotonia and hypogonadism/hypogenitalism. PWS is caused by the loss of paternally expressed genes in the imprinted 15q11q13 chromosome region. About 70% of patients with PWS have a de novo, paternally derived 15q11q13 deletion detected by fluorescence in situ hybridization using small nuclear ribonucleoprotein polypeptide N (SNRPN) as a probe, high-resolution chromosomal microarray or with methylation-specific multiplex ligationdependent probe amplification studies [e.g., Butler et al., 2008; Hamzi et al., 2010; Henkhaus et al., 2012] , while about 25% have uniparental maternal disomy of chromosome 15 (both chromosomes 15 from the mother), and 2% have epigenetic imprinting defects [Bittel and Butler, 2005; Angulo et al., 2015] . DNA methylation is abnormal in 99% of cases but does not determine the specific PWS genetic subtype. The methylation status is often based on analysis of the SNRPN gene in the critical region [Muralidhar and Butler, 1998; Askree et al., 2012] . Deletion of the oculocutaneous albinism type II (OCA2) gene in the distal area of the 15q11q13 critical region is also associated with pigmentation defects of skin, hair, and eyes in PWS. Additionally, there are small nucleolar RNA clusters that largely consist of SNORD116 and SNORD115 , which are imprinted and appear to play a major role in the regulation of the biological metabolism and development of PWS. The deletion or loss of SNORD116 appears to be most likely associated with the PWS phenotype [Sahoo et al., 2008; Hassan and Butler, 2016] .
Clinical Report
We report a male child who was delivered via Cesarean section due to concerns in fetal heart tracing. At delivery, the baby required resuscitation with bag mask ventilation and oxygen. The baby had a weight of 3.572 kg (10-25th percentile), length of 54.5 cm (10-25th percentile), and head circumference of 39.5 cm (50th percentile). The anterior fontanel was large with a slightly overriding sagittal suture. He was noted to have hypotonia, bradycardia, a weak cry, and poor suck with inability to initiate and sustain enteral feeding requiring a normal suck and swallow mechanism. He had a primitive grasp, an incomplete Moro response, and a positional contracture of his left hip. A modified barium swallow showed that he had very poor endurance resulting in a gastrostomy tube placed at 3 weeks of age with removal at 11 months. He had normal pigment pattern for the family background and did not have a micropenis or cryptorchidism. There was a family history of a paternal nephew with cleft palate, deafness, and developmental delay and a maternal cousin with hypoglycemia and seizures. Consequently, his mother underwent fragile X DNA testing which was negative. At the age of 11 months, he developed seizure activity associated with upper respiratory infections or after exposure to excessive heat. Seizures were characterized by eye rolling to the right, slumping over, body stiffening, and tonic-clonic activities. He was treated with valproic acid and memantine HCl.
An EKG revealed sinus bradycardia and minor right ventricular conduction delay. An EEG showed an abnormal 7-to 8-Hz pattern background with slower activity and occipital low amplitude background rhythms with intermittent burst of generalized paradoxical delta or 3-Hz spike and wave activity intermittent with drowsiness. The EEG was considered abnormal for what appeared to be a primary epileptic pattern with occasional right temporal asymmetry in sleep. The epilepsy was stabilized with medication by the age of 5 years.
He had frequent tantrums and began severe skin picking at the age of 3 years leading to chronic bleeding sites. At the age of 4 years, he exhibited anxiety, would become emotional and cry easily with occasional head banging episodes. Beginning at age 5 years, he developed an attention deficit hyperactivity disorder with autistic features including social impairments and repetitive movements/ stereotypies. He had a compulsion for arranging his belongings and liked to play with strings. He had delayed language development and exhibited food seeking with hiding behaviors. A brain MRI revealed adequate gray/white differentiation and symmetry; however, there was prominence of the subarachnoid spaces in the middle cranial fossa bilateral with temporal lobes being small. The frontal horns were also prominent with respect to the ventricular system. The anterior pituitary gland was slightly small for the patient's age, and correlation with pituitary function was recommended.
At the age of 5 years and 9 months, he participated in a multisite, NIH-funded natural history study, RDCRN (Rare Diseases Clinical Research Network). The physical exam revealed a flat occiput, bitemporal narrowing with almond-shaped eyes, strabismus, hypotelorism, upslanting of the eyes, and narrow nasal bridge, relatively small hands and feet, dark pigmentation of hair and skin, and a thin habitus with an abnormal posture ( fig. 1 ). He had a hypernasal voice and pes planus. His weight was 23 kg (60th percentile), height was 120 cm (90th percentile), and head circumference was 52 cm (65th percentile). Medications included valproic acid, memantine HCl, Genotropin, coenzyme Q10, multivitamins, and fish oil. The KBIT2 IQ test was administered, and verbal and nonverbal IQ scores were 65 (1st percentile) and 66 (0.5th percentile), respectively, with a composite IQ score of 61. He was attending special education classes and was in the third grade.
Material and Methods
Cytogenetic analysis was performed and showed an unbalanced de novo reciprocal translocation between the proximal long arm of chromosome 15 and the distal short arm of chromosome .3 ). Subsequently, a highresolution SNP array 6.0 (Affymetrix, Santa Clara, Calif., USA) consisting of 1.8 million copy number and single nucleotide polymorphic probes confirmed an atypical PWS type I deletion of chromosome 15 involving the proximal 15q11q13 breakpoint (BP1) but terminating after the GABRB3 gene and more proximal than the typical distal breakpoint (BP3) at genomic coordinates 22,973,542-27,001,010 bp (hg19) or 4.0 Mb in size. No deletion of band 19p13.3 was found using the standard genome filter parameters for high-resolution microarray analysis. With less restrictive genome filter parameters, a small deletion was found encompassing only the PPAP2C gene.
Results and Discussion
We report an unusual case of PWS with an atypical type I deletion of the 15q11q13 region due to a de novo unbalanced reciprocal translocation, 45,XY,-15,der(19) t(15; 19)(q12;p13.3), resulting in monosomy for the PWS chromosome critical region at 15q11.1q12 of 4.0 Mb in size using high-resolution microarray analysis ( fig. 2 ) . The deletion of the 15q11.1q12 region contained 18 genes/transcripts recognized in OMIM (http://www. omim.org):
We reviewed the literature and noted subjects with PWS and atypical 15q11q13 deletions. For example, Kim et al. [2012] reported 2 cases with PWS having an atypical type I deletion of the 15q11q13 region. A high-resolution SNP microarray revealed a deletion extending from NIPA1 to GABRB3 genes, while the OCA2 gene was intact in both patients ( fig. 3 ) . Case 1 had microcephaly and normal pigmentation but no skin picking and had a pleasant disposition without aggressive behavior. Case 2 had microcephaly, later age onset of obesity, and was reported to be unusually high functioning. These 2 cases and our patient had intact OCA2 genes and did not display hypopigmentation which is generally seen in PWS with the typical 15q11q13 deletion. The OCA2 gene encodes a protein that corresponds to the 'pink-eyed dilution' (p) mouse mutant. The human cDNA DN10, linked to the p locus in mice, identifies the human homolog (P) of the mouse p gene, and appears to encode an integral membrane transporter protein. The human P protein is an 838-amino acid polypeptide that contains 12 putative transmembrane domains and exhibits structural homology to transporters of small organic molecules. Our case also had the GABRB3 (GABA, γ-amino butyric acid) receptor gene deleted, but the GABRA5 and GABRG3 receptor genes located within the 15q11q13 region were intact using standard genome filter parameters for segment length and marker count (i.e., 50 markers per 100 kb segment length) for high-resolution chromosome microarray analysis. GABA plays a major inhibitory neurotransmitter function at the brain level. Using standard genome filter parameters, no genes were deleted from chromosome band 19p13.3. However, when lowering the genome filter parameters to 20 markers and 35 kb segment length, the phosphatidic acid phosphatase type 2C (PPAP2C) gene was deleted. This gene encodes a protein member of the phosphatidic acid phosphatase (PAP) Fig. 1 . Frontal and facial view of our patient at 6 years of age. Craniofacial features included a narrow forehead, triangular shaped facies with a pointed chin, and almond-shaped mildly upslanting eyes. Other physical features included a lean habitus with abnormal posture, hypotonia, darkly pigmented hair and skin, and small hands and feet. 3 . Schematic representation of the 15q11q13 chromosome region displaying the order of genes in the region. Genes in the nonimprinted region are shown in green, while genes in the PWS region are shown in blue. Genes in the Angelman syndrome (AS) region are shown in orange. The 15q11.1q12 deletion seen in our patient included the NIPA1 to GABRB3 genes and is illustrated by the red line. GABRA5 , GABRG3 , and OCA2 or P (pigment) genes located distally in the 15q11q13 region, commonly deleted in PWS, were intact. Breakpoints BP1-BP5 are designated. IC = Imprinting center; T1D = typical 15q11q13 type I deletion; T2D = typical 15q11q13 type II deletion.
family involved in the conversion of phosphatidic acid to diacylglycerol needed for the de novo synthesis of glycerophospholipids and triacylglycerols and the hydrolysis of lysophosphatidic acid, ceramide, and sphingosine which may impact neurodevelopment and brain function (http://www.omim.org).
Although we report a patient with PWS and a deletion associated with an unbalanced de novo chromosome translocation, only a few other reports have been noted in the medical literature [Butler, 1990; Butler and Thompson, 2000; Butler et al., 2006] . Heidemann et al. [2010] summarized 14 individuals with PWS having chromosome translocations, but only 1 case involved chromosomes 15 and 19 [Sun et al., 1996] . This case described a male child with PWS phenotype due to a de novo balanced translocation between chromosomes 15 and 19 involving the PWS critical region on chromosome 15 and the long arm of chromosome 19 and not the short arm as seen in our patient. This patient also did not have a recognized deletion of the 15q11q13 region. Our patient had marked cognitive delays, seizures, and attention deficit hyperactivity disorder in addition to the typical features of PWS including hyperphagia and skin picking but not hypogonadism/hypogenitalism or hypopigmentation, as the OCA2 gene in the 15q11q13 region was not deleted. Peutz-Jeghers disease associated with deletion of STK11 on chromosome 19p13.3 [Peddibhotla et al., 2013] was not present in our patient as this gene was not deleted. Hence, our patient with a translocation involving the 15q11q13 region did not have a recognized deletion of the 19p13.3 band detectable with a high-resolution SNP microarray using standard genome filter parameters. However, when lower genome filter parameters were set, the PPAP2C gene was deleted.
The cause of our patient's atypical features with the t(15; 19)(q12;p13.3) is not clear, although the size of the 15q11q13 deletion was unusual or not typical for PWS. There are other factors that might contribute to the clinical outcome, such as epigenetic factors related to the 15; 19 translocation or process and as yet undefined environmental or genetic factors. Additional research is needed to further explain the role of factors contributing to hyperphagia and obesity in PWS [Hochberg and Hochberg, 2010] ; those patients with an unusual presentation of the PWS phenotype due to atypical genetic causes such as chromosome translocations may shed light on the causation of the key features in this syndrome.
Summary
We report a unique case with an atypical type I deletion of the 15q11q13 region secondary to a translocation involving chromosomes 15 and 19 with intact GABR A5, GABRG3 , and OCA2 genes. The common features of PWS were seen including hypotonia, developmental delay, strabismus, behavioral problems, intellectual disability, speech impairment, and small hands and feet. Atypical features included epilepsy, a lean habitus with an abnormal posture, and marked cognitive delay. PeutzJeghers disease associated with a deletion of the STK11 gene, seen in patients with the 19p13.3 deletion, was not found in our patient. High-resolution SNP microarray analysis was useful in confirming the absence of the deletion of chromosome 19p to rule out Peutz-Jeghers disease and associated tumors. Studying individuals with atypical deletions may offer further opportunities to explain the spectrum and causation of PWS. We encourage other authors to report subjects with PWS and unique chromosomal anomalies including translocations involving the 15q11q13 region to increase our understanding of causation and unique function of overlapping genetic regions on 2 separate translocated chromosomes.
